A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
PHASE2
Researchers are looking for new ways to treat metastatic nonsquamous non-sm...
Status
Recruiting
Location
University of Kentucky Chandler Medical Center ( Site 0019)
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
PHASE2
Researchers are looking for other ways to treat metastatic squamous non-sma...
Status
Recruiting
Location
University of Kentucky Chandler Medical Center ( Site 0019)
A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
PHASE3
Researchers are looking for new ways to treat advanced, high-grade ovarian ...
A Study of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab as Maintenance Therapy in Second-Line Platinum-Sensitive Recurrent Ovarian Cancer (REJOICE-Ovarian03)
PHASE3
The primary purpose of the study is to evaluate the efficacy of R-DXd with ...